SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Acer Therapeutics Inc. – ‘8-K’ for 5/14/18 – ‘EX-4.1’

On:  Tuesday, 5/15/18, at 4:00pm ET   ·   For:  5/14/18   ·   Accession #:  1564590-18-13619   ·   File #:  1-33004

Previous ‘8-K’:  ‘8-K’ on / for 5/14/18   ·   Next:  ‘8-K’ on / for 6/29/18   ·   Latest:  ‘8-K’ on 11/20/23 for 11/17/23   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/15/18  Acer Therapeutics Inc.            8-K:3,5,9   5/14/18    9:1.1M                                   ActiveDisclosure/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     51K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    224K 
                          Liquidation or Succession                              
 3: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     15K 
 4: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     12K 
 5: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     26K 
 6: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    109K 
 7: EX-3.5      Articles of Incorporation/Organization or By-Laws   HTML     16K 
 8: EX-4.1      Instrument Defining the Rights of Security Holders  HTML      9K 
 9: EX-10.3     Material Contract                                   HTML     51K 


EX-4.1   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 4.1

 

SEE REVERSE FOR IMPORTANT NOTICE REGARDING OWNERSHIP AND  TRANSFER RESTRICTIONS AND CERTAIN OTHER INFORMATION  PRESIDENT AND CEO  transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of this certificate properly  endorsed. This Certificate and the shares represented hereby are issued and shall be held subject to the laws of the State of Delaware and to all of the  provisions of the Certificate of Incorporation and Bylaws of the Corporation, as now in effect or as hereafter amended, and the holder of this Certificate, by  acceptance hereof, assents to all such provisions.  INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE  COMMON STOCK SEE REVERSE FOR CERTAIN DEFINITIONS  FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK, $0.0001 PAR VALUE PER SHARE OF  Acer TherApeuTics inc.  CUSIP 00444P108  CORPORATE SECRETARY  This Certificate is not valid until countersigned by the Transfer Agent and registered by the Registrar.  WITNESS the facsimile signatures of its duly authorized officers.  (Text Box comment  SPECIMEN ) Stock  transfer

 

 


 

The Corporation will furnish without charge to each holder who so requests a statement of the powers, designations, preferences and relative,  participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such  preferences and/or rights. Such requests shall be made to the Corporation’s Secretary at the principal office of the Corporation. A statement  of these rights is also set forth in the Corporation’s Certificate of Incorporation on file in the office of the Secretary of State. The following abbreviations, when used in the inscription on the face certificate, shall be construed as though they were written out in full according to applicable laws or regulations: TEN COM – as tenants in common UNIF GIFT MIN ACT-  Custodian  (Cust)(Minor) TEN ENT - as tenants by the entiretiesunder Uniform Gifts to Minors IT TEN -as joint tenants with right of Act  (State) survivorship and not as tenants in common TTEE  -trustee under Agreement dated  Additional abbreviations may also be used though not in the above list. For value received, hereby sell, assign and transfer unto  PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE,  Shares of the common stock represented by this certificate and do hereby irrevocably Constitute and appoint  attorney, to transfer the said stock on  the books of the within-named corporation with full power of substitution in the premises. DATED     NOTICE: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular without alteration or enlargement or any change whatever.SIGNATURE GUARANTEED:  THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.


15 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/23  Acer Therapeutics Inc.            10-Q        6/30/23   65:13M                                    Donnelley … Solutions/FA
 5/15/23  Acer Therapeutics Inc.            10-Q        3/31/23   63:13M                                    Donnelley … Solutions/FA
 3/27/23  Acer Therapeutics Inc.            S-8         3/27/23    4:66K                                    Donnelley … Solutions/FA
 3/27/23  Acer Therapeutics Inc.            10-K       12/31/22   68:13M                                    Donnelley … Solutions/FA
11/14/22  Acer Therapeutics Inc.            10-Q        9/30/22   62:9.7M                                   ActiveDisclosure/FA
11/14/22  Acer Therapeutics Inc.            10-Q/A      6/30/22   65:9.9M                                   ActiveDisclosure/FA
 8/15/22  Acer Therapeutics Inc.            10-Q        6/30/22   60:8.9M                                   ActiveDisclosure/FA
 3/03/22  Acer Therapeutics Inc.            S-8         3/03/22    4:69K                                    Donnelley … Solutions/FA
 3/02/22  Acer Therapeutics Inc.            10-K       12/31/21   61:12M                                    ActiveDisclosure/FA
12/03/21  Acer Therapeutics Inc.            S-3/A                  2:285K                                   Donnelley … Solutions/FA
11/24/21  Acer Therapeutics Inc.            S-3                    4:642K                                   Donnelley … Solutions/FA
 3/03/21  Acer Therapeutics Inc.            S-1                    3:645K                                   Donnelley … Solutions/FA
 3/03/21  Acer Therapeutics Inc.            424B2                  1:427K                                   Donnelley … Solutions/FA
 3/01/21  Acer Therapeutics Inc.            10-K       12/31/20   60:8.9M                                   ActiveDisclosure/FA
 3/01/21  Acer Therapeutics Inc.            S-8         3/01/21    3:58K                                    Donnelley … Solutions/FA
Top
Filing Submission 0001564590-18-013619   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 10:06:35.3am ET